Get started
Author

Sonia Pezet

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 · Muriel Elhai, Anna Maria Hoffmann‐Vold, et al. · Arthritis & Rheumatology · 141
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
2016 · Nadira Ruzehaji, Camelia Frantz, et al. · Annals of the Rheumatic Diseases · 101
PDF
OX40L blockade protects against inflammation-driven fibrosis
2016 · Muriel Elhai, Jérôme Avouac, et al. · Proceedings of the National Academy of Sciences · 80
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
2017 · Jerome Avouac, Irena Konstantinova, et al. · Annals of the Rheumatic Diseases · 78
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis
2016 · Matthieu Ponsoye, Camelia Frantz, et al. · Annals of the Rheumatic Diseases · 70
T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis
2018 · Gonçalo Boleto, Christophe Guignabert, et al. · Arthritis Research & Therapy · 56
PDF
Estrogens Counteract the Profibrotic Effects of TGF-β and their Inhibition Exacerbates Experimental Dermal Fibrosis
2019 · Jérôme Avouac, Sonia Pezet, et al. · Journal of Investigative Dermatology · 37
PDF
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
2018 · Camelia Frantz, Sonia Pezet, et al. · Disease Markers · 37
PDF
Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis
2021 · Jérôme Avouac, Sonia Pezet, et al. · Arthritis & Rheumatology · 35
Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis
2020 · Agathe Leblond, Sonia Pezet, et al. · Annals of the Rheumatic Diseases · 28
PDF
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis
2017 · Jérôme Avouac, Christophe Guignabert, et al. · Arthritis & Rheumatology · 25
PDF
Characterization of SMA type II skeletal muscle from treated patients shows OXPHOS deficiency and denervation
2024 · Fiorella Carla Grandi, Stéphanie Astord, et al. · JCI Insight · 9
Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis
2018 · Agathe Leblond, Sonia Pezet, et al. · PLoS ONE · 6
PDF
Identification of CaVβ1 Isoforms Required for Neuromuscular Junction Formation and Maintenance
2025 · Vergnol Amélie, Bourguiba Aly, et al. · Cells · 2
PDF
Systemic Factors Affect Bone Health in SMA Type II Patients and a Mouse Model of SMA
2025 · Fiorella Carla Grandi, Sonia Pezet, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
SMA Type II Skeletal Muscle Treated with Nusinersen shows SMN Restoration but Mitochondrial Deficiency.
2024 · Fiorella Carla Grandi, Stephanie Astord, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Sat0038 Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis
2019 · Jérôme Avouac, Sonia Pezet, et al. · Annals of the Rheumatic Diseases · 1
PDF
OP0095 Soluble cd163 as a potential biomarker in systemic sclerosis
2018 · C. Frantz, S. Pezet, et al. · Annals of the Rheumatic Diseases · 1
PDF
The thymus gland is a target and maintainer of amyotrophic lateral sclerosis pathophysiology
2026 · Julia Pereira Lemos, Daniel Stockholm, et al. · Brain Behavior & Immunity - Health
GDF5 as a Multimodal Protector of the Motor Unit in Amyotrophic Lateral Sclerosis
2026 · Aly Bourguiba, Sonia Pezet, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Pre-clinical evaluation of a gene therapy candidate for SOD1 -ALS shows improved survival and signs of inflammation in the CNS of treated mice
2025 · Pezet Sonia, Hua Jennifer, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
577PMultisystemic factors from muscle and liver affect bone health in spinal muscular atrophy type II patients and a mouse model
2025 · F. Grandi, S. Pezet, et al. · Neuromuscular Disorders
177P Effect of gene therapy on the epigenetic and transcriptional stability of SMA
2024 · P. Smeriglio, F. Grandi, et al. · Neuromuscular Disorders
178P Spinal muscular atrophy type II skeletal muscle treated with Nusinersen and Risdiplam shows SMN restoration but mitochondrial deficiency
2024 · F. Grandi, S. Astord, et al. · Neuromuscular Disorders
GDF5 therapeutic potential on neuromuscular junction defects
2024 · BOURGUIBA VILLENEUVE, Aly, Pezet, Sonia, et al. · HAL (Le Centre pour la Communication Scientifique Directe)
Works count: 44
Citation count: 709
H-index: 11
I10-index: 11
Year
Topic
Type